Evidence map›Paper›PMID 42266762›Full record

ArticleAmerican journal of cancer research2026

Curcumin induces ferroptosis in ovarian cancer cells through the Nrf2/GPX4 regulation axis.

Nan Liu, Ye-Ting Cui, Yi Zheng, Shu-Min Fang, Li-Xi Liao, Ting-Ting Luo, Ze-Hui Zhong, Xiao-Yu Hu, Ming-Hui Zhou, Yan-Yang Tu

Abstract read
In one paragraph

Article in American journal of cancer research, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 2 papers.

0numbers the graph read from it
0cells of the map it votes in
2citing papers in PubMed
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

2 citing papers in PubMed.

  1. Review
  2. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

10 authors.

Nan LiuGuangdong Provincial Science and Technology Expert Workstation, Huizhou Central People's Hospital Huizhou 516001, Guangdong, China.
Ye-Ting CuiGuangdong Provincial Science and Technology Expert Workstation, Huizhou Central People's Hospital Huizhou 516001, Guangdong, China.
Yi ZhengScience Research Center, Huizhou Central People's Hospital Huizhou 516001, Guangdong, China.
Shu-Min FangScience Research Center, Huizhou Central People's Hospital Huizhou 516001, Guangdong, China.
Li-Xi LiaoScience Research Center, Huizhou Central People's Hospital Huizhou 516001, Guangdong, China.
Ting-Ting LuoScience Research Center, Huizhou Central People's Hospital Huizhou 516001, Guangdong, China.
Ze-Hui ZhongScience Research Center, Huizhou Central People's Hospital Huizhou 516001, Guangdong, China.
Xiao-Yu HuScience Research Center, Huizhou Central People's Hospital Huizhou 516001, Guangdong, China.
Ming-Hui ZhouDepartment of Gynecology, Huizhou Central People's Hospital Huizhou 516001, Guangdong, China.
Yan-Yang TuScience Research Center, Huizhou Central People's Hospital Huizhou 516001, Guangdong, China.

Funding

No grant is acknowledged in the PubMed record.

6 · The paper itself

Abstract

Ovarian cancer (OC) frequently develops acquired resistance to traditional anti-tumor treatments, highlighting the urgent need for novel therapeutic strategies. This study investigated whether curcumin can induce ferroptosis in OC cells through the Nrf2/GPX4 regulation axis, and whether Nrf2 overexpression can confer resistance to curcumin in OC cells. SK-OV-3 and A2780 cells were treated with curcumin, and the effects on cell viability, migration, and invasion were evaluated using Cell Counting Kit-8 (CCK-8), wound healing, Transwell assay, and flow cytometry. Ferroptosis-associated changes were assessed by measuring intracellular Fe

Indexed as

apoptosiscurcuminferroptosisNrf2/GPX4 axisOvarian canceroxidative stress

Identifiers

PMID42266762
PMCPMC13243678

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.